Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-105-1 | CAS number: 103-37-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute toxicity: Oral
The reported study was designed and conducted to determine the acute oral toxicity profile of the given test chemical. Acute oral toxicity study was performed in groups of 10 young adult Osborne-Mendel rats evenly divided by sex using test chemical at dose concentration of 2330 mg/kg bw. 50% mortality was observed at dose 2330 mg/kg bw.Clinical signs like somnolence (general depressed activity), Scrawny appearance, tremors at higher doses were observed. Hence, LD50 value was considered to be 2330 mg/kg bw (1940-2800) with 95% confidence limits, when rats were treated with test chemical orally.
Acute toxicity: Inhalation
The study doesnot need to be conducted because exposure of humans via inhalation is not likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size.Test chemical has very low vapour pressure (6.5061 Pa.= 0.0487997562 mmHg),So the potential for the generation of inhalable vapours is very low. Also the normal conditions of use of this substance will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalatory route will be highly unlikely and therefore the acute inhalation toxicity end point was considered for waiver
Acute toxicity: Dermal
The reported study was designed and conducted to determine the acute dermal toxicity profile of the given test chemical. In acute dermal toxicity study, five rabbits were treated with test chemical in the concentration of 5000 mg/kg bw by dermal application followed by a 14 days observation period. No mortality was observed in treated rabbits at dose 5000 mg/kg bw. Necropsy was not conducted. Therefore, LD50 value was considered to be >5000 mg/kg bw,when rabbits were treated with test chemical by dermal application.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data is from peer reviewed journal
- Qualifier:
- according to guideline
- Guideline:
- other: as mentioned below
- Principles of method if other than guideline:
- Acute Oral toxicity test was carried out to study the effects of test chemical on rats.
- GLP compliance:
- not specified
- Test type:
- other: No data available
- Species:
- rat
- Strain:
- Osborne-Mendel
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: young and adult rats
- Fasting period before study: 18 hours approx
- Diet (e.g. ad libitum): the food was replaced in cages as soon as animals received their respective doses.
- Water (e.g. ad libitum): ad libitum - Route of administration:
- other: intubation
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- The test material was applied undiluted
- Doses:
- 2330 mg/kg
- No. of animals per sex per dose:
- 10:animals
5 : males
5 : females - Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Necropsy of survivors performed: No
- Other examinations performed: clinical signs, body weight, mortality - Statistics:
- LD50's were computed by the method of Litchfield & Wilcoxon (1949)
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 330 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 1 940 - <= 2 800
- Remarks on result:
- other: 50% mortality was observed
- Mortality:
- Mortality were observed in 4hrs-4 days
- Clinical signs:
- other: Depression, scrawny appearance, tremors with higher doses
- Gross pathology:
- Necropsy was not conducted
- Other findings:
- no data available
- Interpretation of results:
- other: not classified
- Conclusions:
- The lethal concentration (LD50) value for acute oral toxicity test was considered to be 2330 mg/kg bw (95% confidence limit:1940-2800),when group of 5 male and female Osborne-Mendel rats were treated with test chemical orally.
- Executive summary:
Acute oral toxicity study was performed in groups of 10 young adult Osborne-Mendel rats evenly divided by sexusing test chemical at dose concentration of 2330 mg/kg bw.All doses were given by intubation. All animals were maintained under close observation for recording toxic signs and time of death. Such observation was continued until animals appeared normal and showed weight gain. The usual observation period was 2 weeks. LD50's were computed by the method of Litchfield & Wilcoxon (1949).The substance was a liquid and it was administered undiluted.50% mortality was observed at dose 2330 mg/kg bw.Clinical signs like somnolence (general depressed activity), Scrawny appearance, tremors at higher doses were observed. Hence,LD50 value was considered to be 2330 mg/kg bw (1940-2800) with 95% confidence limits,when rats were treated withtest chemical orally.
Reference
Acute oral toxicity of food flavourings and compounds of related structure
CAS |
Species |
LD50 with 95 % confidence limits (mg/kg) |
Slope function with 95% confidence limits |
Toxic sign and death time (D.T) |
103 -37 -7 |
Rat |
2330 (1940-2800) |
1:3 (1.1- 1.6) |
Depression, scrawny appearance, tremors with higher doses D.T. 4hrs-4 days |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 330 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from peer reviewed journal
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- exposure considerations
- Justification for data waiving:
- the study does not need to be conducted because exposure of humans via inhalation is not likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size
- Clinical signs:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
- Quality of whole database:
- waiver
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data is from peer reviewed journal
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- Acute dermal toxicity study of test chemical was performed in rabbits.
- GLP compliance:
- not specified
- Test type:
- other: not specified
- Limit test:
- no
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- No data available
- Type of coverage:
- not specified
- Vehicle:
- not specified
- Details on dermal exposure:
- No data available
- Duration of exposure:
- No data available
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 5 animals
- Control animals:
- not specified
- Details on study design:
- Details on study design
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: 14 days
- Necropsy of survivors performed: no
- Other examinations performed: clinical signs and mortality
other: No data available - Statistics:
- No data available
- Preliminary study:
- No data available
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no mortality was observed
- Mortality:
- No mortality was observed in rabbits dosed with 5000 mg/kg bw.
- Clinical signs:
- other: No clinical signs observed
- Gross pathology:
- No data available
- Other findings:
- No data available
- Interpretation of results:
- other: not classified
- Conclusions:
- The LD50 value was considered to be >5000 mg/kg bw,when five rabbits were treated with test chemical by dermal application following 14 days of observation period.
- Executive summary:
In acute dermal toxicity study, five rabbits were treated with test chemical in the concentration of 5000 mg/kg bw by dermal application followed by a 14 days observation period.No mortality was observed in treated rabbits at dose 5000 mg/kg bw. Necropsy was not conducted. Therefore, LD50 value was considered to be >5000 mg/kg bw,when rabbits were treated with test chemical by dermal application.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from peer reviewed journal
Additional information
Acute toxicity: Oral
In different studies, the given test chemical has been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats for test chemical. The studies are summarized as below –
The reported study was designed and conducted to determine the acute oral toxicity profile of the given test chemical. Acute oral toxicity study was performed in groups of 10 young adult Osborne-Mendel rats evenly divided by sex using test chemical at dose concentration of 2330 mg/kg bw.All doses were given by intubation. All animals were maintained under close observation for recording toxic signs and time of death. Such observation was continued until animals appeared normal and showed weight gain. The usual observation period was 2 weeks. LD50's were computed by the method of Litchfield & Wilcoxon (1949). The substance was a liquid and it was administered undiluted.50% mortality was observed at dose 2330 mg/kg bw.Clinical signs like somnolence (general depressed activity), Scrawny appearance, tremors at higher doses were observed. Hence, LD50 value was considered to be 2330 mg/kg bw (1940-2800) with 95% confidence limits, when rats were treated with test chemical orally.
The above study is supported with another study conducted on rats for the test chemical. Acute oral toxicity study was performed in rats using test chemical at dose concentration of 2300 mg/kg bw.50% mortality was observed at dose 2300 mg/kg bw. Hence,LD50 value was considered to be 2300 mg/kg bw,when rats were treated with test chemical orally.
Both the above studies were again supported by another study performed in 10 rats using test chemical at dose concentration of 1900 mg/kg bw.50% mortality was observed at dose1900 mg/kg bw. Hence, LD50 value was considered to be1900 mg/kg bw(95% confidence limits :1100 - 2600),when rats were treated with test chemical orally.
Furthermore, all the above studies were again supported performed in rats using test chemicaat dose concentration of 1850 mg/kg bw.The test chemical was administered by gavage to rats (10/group) at doses of 1480, 2220, 3330 or 5000 mg/kg bw followed by a 14 day observation period.The incidence of mortality was 0/10, 7/10, 8/10 and 9/10 from low to high dose. All deaths occurred by day 9 with most by day 2. Clinical signs of toxicity at 2220 mg/kg and above included lethargy and chromodacryorrhea. Necropsy was not conducted.Hence,LD50 value was considered to be1850 mg/kg bw(95% confidence limits :1060-2560),when rats were treated with test chemical orally via gavage.
Though, 1900 and 1850 mg/kg bw LD50 values for test chemical were available but most of the references suggest that the test chemical is likely to be non-toxic via oral route. Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the test chemical can be classified under “Not Classified”.
Acute toxicity: Inhalation
The study doesnot need to be conducted because exposure of humans via inhalation is not likely taking into account the vapour pressure of the substance and/or the possibility of exposure to aerosols, particles or droplets of an inhalable size.Test chemical has very low vapour pressure (6.5061 Pa.= 0.0487997562 mmHg),So the potential for the generation of inhalable vapours is very low. Also the normal conditions of use of this substance will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalatory route will be highly unlikely and therefore the acute inhalation toxicity end point was considered for waiver
Acute toxicity: Dermal
In different studies, the given test chemical has been investigated for acute dermal toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rabbits for test chemical. The studies are summarized as below -
The reported study was designed and conducted to determine the acute dermal toxicity profile of the given test chemical. In acute dermal toxicity study, five rabbits were treated with test chemical in the concentration of 5000 mg/kg bw by dermal application followed by a 14 days observation period.No mortality was observed in treated rabbits at dose 5000 mg/kg bw. Necropsy was not conducted. Therefore, LD50 value was considered to be >5000 mg/kg bw,when rabbits were treated with test chemical by dermal application.
The above study is supported with another experimental study conducted on rats for the test chemical as per OECD No.402. 10 male and female healthy young adult Wistar rats were randomly selected and used for conducting acute dermal toxicity study at the concentration of 2000 mg/kg bw. Rats free from injury and irritation of skin were selected for the study. 24 hours prior to dermal application of test item, approximately 10% of body surface area of each rat was clipped. A limit dose of 2000 mg/ kg body weight of test item was applied by single dermal application and observed for 14 days after treatment. On test day 0, as such amount of test item, calculated based on density (1.0016) and body weight was applied directly on the intact skin of clipped area of rats; the surgical gauze patch was put on to the intact skin of clipped area. This porous gauze dressing was covered with a non-irritating adhesive tape. The porous gauze dressing was wrapped around the abdomen and anchored with non-irritating adhesive tape. After the 24-hour application period, the dressings were removed and the skin was gently wiped with distilled water. The skin reactions were assessed. The animals were observed daily for mortality and clinical signs, during the acclimatization period. All animals were observed for clinical signs at approximately 1, 2, 3 and 4 hours after treatment on day 0 and once daily during test days 1‑14. Mortality was recorded after application on test day 0 and twice daily during days 1-14 (at least once on the day of sacrifice). Local signs / Skin reactions were observed daily from test days 1-14 (in common with clinical signs). Body weights were recorded on day 0 (prior to application) and on day 7 and 14. All animals were necropsied and examined macroscopically. No mortality was observed in any animal till the end of the experimental period. No clinical signs and any skin reaction were observed throughout the experimental period in all treated animals. The male and female animals were observed with body weight gain throughout the experiment, except on day 7 male animals were observed with decline in mean body weight gain as compared to day 0. The external and internal gross pathological observation of all terminally sacrificed animals did not show any pathological abnormality. Hence the LD50 was considered to be >2000 mg/kg bw,when rats were treated with test chemical by dermal application.
Both the above studies are further supported with a similar acute dermal toxicity study, rabbits were treated with test chemical in the concentration of 5000 mg/kg dermal application. No mortality was observed in rabbits at 5000 mg/kg. Therefore, LD50 was considered to be > 5000 mg/kg bw when rabbits were treated with test chemical by dermal application.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is >2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the test chemical can be classified under “Not Classified”.
Justification for classification or non-classification
Based on the available results, the test chemical is likely to be non-toxic when exposed via oral, dermal or inhalation route. Hence, it can be classified under the category "Not Classified" as per CLP Regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.